P&G Q4 Results Beat Market; Sees Growth In FY26

Procter & Gamble (PG) exceeded fourth-quarter expectations, reporting net earnings of $3.62 billion ($1.48/share) and revenue of $20.89 billion. Looking ahead to fiscal 2026, the consumer goods giant issued guidance for core earnings per share growth of flat to 4% ($6.83-$7.09/share), with a mid-point of $6.96 below analyst consensus of $7, and organic sales growth of flat to 4%. This outlook anticipates approximately $800 million in higher tariff costs, and P&G shares reacted with a modest 0.8% pre-market gain.

Analysis

Procter & Gamble (PG) reported fourth-quarter results that surpassed market expectations, with adjusted EPS of $1.48 beating the consensus estimate of $1.42 and revenue of $20.89 billion slightly exceeding the anticipated $20.84 billion. However, the company's forward-looking guidance for fiscal 2026 presents a more cautious outlook. Management forecasts core EPS growth in a range of flat to 4%, translating to $6.83-$7.09 per share. The midpoint of this guidance, $6.96, falls slightly below the Wall Street consensus of $7.00 per share, indicating potential pressure on future profitability. This muted earnings forecast is influenced by significant anticipated headwinds, most notably an estimated $800 million in higher costs from tariffs. The outlook also accounts for a net negative impact from special items, including a gain from the Glad joint venture exit ($0.10-$0.13 per share) offset by larger non-core restructuring charges ($0.12-$0.25 per share). The organic sales growth projection of flat to 4% further suggests a potential deceleration, reflecting a challenging environment. Despite the historical earnings beat, the cautious guidance likely tempered investor enthusiasm, as reflected by the modest 0.8% pre-market share price increase.

Key Decisions for Investors

• Investors should weigh the solid fourth-quarter earnings beat against the more cautious fiscal 2026 guidance, whose midpoint for core EPS falls below analyst consensus.
• Monitor the impact of the projected $800 million in tariff-related costs, as this represents a significant headwind to profitability and a key risk to achieving the guided earnings range.
• Closely track organic sales growth figures in upcoming quarters, as the wide guidance range of flat to 4% indicates uncertainty and a potential slowdown in consumer demand.
• Given the muted growth outlook and external cost pressures, it may be prudent to assess if the current valuation fully reflects the forecasted earnings deceleration before increasing a long position.